Echelon Biosciences, Inc. is a cell biology assay and reagents company in the rapidly expanding field of lipid signaling. Our focus is on PI3-Kinase, phosphoinsotide signaling, sphingolipids, lysolipids, the heme pathway, isoprenoids, and extracellular matrix components.
Echelon Biosciences was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, and was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. The company has since changed its name to Echelon Biosciences Incorporated. The company was organized to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.